Cortalix

Groningen, The Netherlands

Cortalix is a biotechnological company developing PET-imaging diagnostics, targeted radiotherapeutics, CAR-T immunotherapeutics.

$1.1M raised

Mar 2025

Seed

Top Investors

RabobankFuture Tech Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Cortalix raised?

Cortalix has raised $1.1M in total funding. The most recent round was Seed. The last funding was announced in March 2025.

Who are Cortalix's investors?

Cortalix's investors include Rabobank, Future Tech Ventures.

Where is Cortalix headquartered?

Cortalix is headquartered in Groningen, The Netherlands.

What does Cortalix do?

Cortalix is a biotechnological company developing PET-imaging diagnostics, targeted radiotherapeutics, CAR-T immunotherapeutics.

What stage is Cortalix at?

Cortalix is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 10, 2025.

MLA

"Cortalix — Funding & Investors." VCBacked, March 10, 2025, https://www.vcbacked.co/company/cortalix. Accessed June 17, 2026.

APA

VCBacked. (2025). Cortalix — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/cortalix

Wikipedia (cite web)

{{cite web |title=Cortalix — Funding & Investors |url=https://www.vcbacked.co/company/cortalix |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 10, 2025.